INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

Clinical trial NCT04130854 · COMPLETED

Trial details

NCT number: NCT04130854
Sponsor: University of Texas Southwestern Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Rectal Adenocarcinoma

Start date: 2020-04-24
Primary completion: 2026-01-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.